Tivozanib Is the Gift That Keeps on Giving for Aveo
ThinkstockAveo Pharmaceuticals Inc. (NASDAQ: AVEO) has been on a roller coaster for the past few months. Previously Aveo made a 50% run in May after it released details regarding its study of renal cell…